glp-1 receptor agonist manufacturers Market Size & Analysis, 2026-2033 GLP-1 Receptor Agonist Market Size

Clinical effects of glucagon-like peptide-1 agonist use for weight loss in women with polycystic ovary syndrome: a scoping review

[DOI] [PubMed] [Google Scholar] 65.Bornebusch A.B., Fink-Jensen A., Wrtwein G., Seeley R.J., Thomsen M

Studies in patients with type 2 diabetes and obesity have demonstrated that the use of SGLT2 inhibitors, particularly empagliflozin, not only increases overall cancer risk but also significantly elevates the risk of bladder cancer [10, 108]

Significance This systematic review highlights the potential therapeutic impact of GLP-1 receptor agonists in reducing substance use disorders in adult patients

With more than 30% of the U.S